Legend Biotech Corporation

About Legend Biotech Corporation

Legend Biotech is dedicated to quality and driven by excellence, committed to improving the lives of patients worldwide through the development of cutting-edge cell therapies. They focus on serious, intractable, and incurable diseases, particularly in hematologic malignancies and solid tumors, with a mission to transform the world of oncology and medicine.

Products & Services

Cell Therapies:A pipeline of investigational agents targeting hematologic malignancies and solid tumors, focusing on personalized medicine and innovative technologies.

CARVYKTI(r):A therapy for multiple myeloma with groundbreaking 5-year survival data presented at the 2025 ASCO Annual Meeting.

Specialties

Cell Therapies Hematologic Malignancies Solid Tumors Oncology Personalized Medicine Innovative Therapeutic Technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 350000000 MR: - FA: 350 million FAN: 350000000	D: 2023-05-08 FD: 2023-05-08	-

Registered Direct Offering Latest

2023-05-08

$350.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Y

Ying Huang

CHIEF EXECUTIVE OFFICER

A

Alan Bash

President of CARVYKTI(r)

G

Guowei Fang

President of Research and Development

C

Carlos Santos

Chief Financial Officer

M

Mythili Koneru

CHIEF MEDICAL OFFICER

J

Jim Pepin

GENERAL COUNSEL

View 19 more team members with Pro

Unlock Full Team Directory

Recent News